Literature DB >> 17988865

Synthesis and evaluation of novel aromatic substrates and competitive inhibitors of GABA aminotransferase.

Michael D Clift1, Richard B Silverman.   

Abstract

The design, synthesis, and evaluation of novel gamma-aminobutyric acid aminotransferase (GABA-AT) inhibitors and inactivators can lead to the discovery of new GABA-related therapeutics. To this end, a series of aromatic amino acid compounds was synthesized to aid in the design of new inhibitors and inactivators of GABA-AT. All compounds were tested as competitive inhibitors of GABA-AT. The amino acids with benzylic amines were also tested as substrates for GABA-AT. It was found that these compounds were all poor competitive inhibitors of GABA-AT, but some were substrates of the enzyme, suggesting their utility as scaffolds for potential GABA-AT mechanism-based inactivators. Computer modeling was used to rationalize the substrate activity of the various compounds.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17988865      PMCID: PMC2480492          DOI: 10.1016/j.bmcl.2007.10.060

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  11 in total

1.  Disposition of gamma-aminobutyric acid administered to mammals.

Authors:  N M VAN GELDER; K A ELLIOTT
Journal:  J Neurochem       Date:  1958-12       Impact factor: 5.372

2.  Soluble gamma-aminobutyric-glutamic transaminase from Pseudomonas fluorescens.

Authors:  E M SCOTT; W B JAKOBY
Journal:  J Biol Chem       Date:  1959-04       Impact factor: 5.157

3.  Crystal structure of GABA-aminotransferase, a target for antiepileptic drug therapy.

Authors:  P Storici; G Capitani; D De Biase; M Moser; R A John; J N Jansonius; T Schirmer
Journal:  Biochemistry       Date:  1999-07-06       Impact factor: 3.162

Review 4.  gamma-Aminobutyric acid agonists, antagonists, and uptake inhibitors. Design and therapeutic aspects.

Authors:  P Krogsgaard-Larsen
Journal:  J Med Chem       Date:  1981-12       Impact factor: 7.446

5.  Effect of the convulsive agent 3-mercaptopropionic acid on the levels of GABA, other amino acids and glutamate decarboxylase in different regions of the rat brain.

Authors:  A Karlsson; F Fonnum; D Malthe-Sorenssen; J Storm-Mathisen
Journal:  Biochem Pharmacol       Date:  1974-11-01       Impact factor: 5.858

6.  Correlation of cortical cholinergic and GABA deficits with quantitative neuropathological findings in senile dementia.

Authors:  C Q Mountjoy; M N Rossor; L L Iversen; M Roth
Journal:  Brain       Date:  1984-06       Impact factor: 13.501

7.  CSF GABA levels in Parkinson's disease.

Authors:  P J de Jong; J P Lakke; A W Teelken
Journal:  Adv Neurol       Date:  1984

8.  Structures of gamma-aminobutyric acid (GABA) aminotransferase, a pyridoxal 5'-phosphate, and [2Fe-2S] cluster-containing enzyme, complexed with gamma-ethynyl-GABA and with the antiepilepsy drug vigabatrin.

Authors:  Paola Storici; Daniela De Biase; Francesco Bossa; Stefano Bruno; Andrea Mozzarelli; Caroline Peneff; Richard B Silverman; Tilman Schirmer
Journal:  J Biol Chem       Date:  2003-10-08       Impact factor: 5.157

Review 9.  Basic aspects of GABA-transaminase in neuropsychiatric disorders.

Authors:  F M Sherif; S S Ahmed
Journal:  Clin Biochem       Date:  1995-04       Impact factor: 3.281

10.  Design, synthesis, and biological activity of a difluoro-substituted, conformationally rigid vigabatrin analogue as a potent gamma-aminobutyric acid aminotransferase inhibitor.

Authors:  Yue Pan; Jian Qiu; Richard B Silverman
Journal:  J Med Chem       Date:  2003-12-04       Impact factor: 7.446

View more
  4 in total

1.  Synthesis and evaluation of novel heteroaromatic substrates of GABA aminotransferase.

Authors:  Dustin D Hawker; Richard B Silverman
Journal:  Bioorg Med Chem       Date:  2012-08-16       Impact factor: 3.641

2.  Pharmacomodulation of the Antimalarial Plasmodione: Synthesis of Biaryl- and N-Arylalkylamine Analogues, Antimalarial Activities and Physicochemical Properties.

Authors:  Karène Urgin; Mouhamad Jida; Katharina Ehrhardt; Tobias Müller; Michael Lanzer; Louis Maes; Mourad Elhabiri; Elisabeth Davioud-Charvet
Journal:  Molecules       Date:  2017-01-19       Impact factor: 4.411

3.  QSAR and Molecular Docking Studies of the Inhibitory Activity of Novel Heterocyclic GABA Analogues over GABA-AT.

Authors:  Josué Rodríguez-Lozada; Erika Tovar-Gudiño; Juan Alberto Guevara-Salazar; Rodrigo Said Razo-Hernández; Ángel Santiago; Nina Pastor; Mario Fernández-Zertuche
Journal:  Molecules       Date:  2018-11-15       Impact factor: 4.411

4.  Novel-Substituted Heterocyclic GABA Analogues. Enzymatic Activity against the GABA-AT Enzyme from Pseudomonas fluorescens and In Silico Molecular Modeling.

Authors:  Erika Tovar-Gudiño; Juan Alberto Guevara-Salazar; José Raúl Bahena-Herrera; José Guadalupe Trujillo-Ferrara; Zuleyma Martínez-Campos; Rodrigo Said Razo-Hernández; Ángel Santiago; Nina Pastor; Mario Fernández-Zertuche
Journal:  Molecules       Date:  2018-05-09       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.